Shinnosuke Tazawa

Title: Shinnosuke Tazawa: Innovator in Pharmaceutical Crystallization

Introduction

Shinnosuke Tazawa is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of specific crystal forms of important compounds. With a total of two patents to his name, Tazawa's work has implications for both industrial applications and therapeutic advancements.

Latest Patents

Tazawa's latest patents include a method for producing alpha form crystals of sapropterin hydrochloride. This innovative method involves dissolving sapropterin hydrochloride with hydrochloric acid at a concentration of not less than 4 mol/L at temperatures exceeding 70 degrees Celsius. The process continues with the addition of heated ethanol and a controlled cooling rate to precipitate the desired crystals. Another significant patent is for a method of producing L-biopterin on a large industrial scale. This method utilizes inexpensive and easy-to-handle reagents, eliminating the need for specialized equipment or facilities.

Career Highlights

Throughout his career, Tazawa has worked with reputable companies such as Shiratori Pharmaceutical Co., Ltd. and Asubio Pharma Co. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical technologies.

Collaborations

Tazawa has collaborated with notable colleagues, including Katsumi Hotoda and Hiroomi Kiyono. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical methods.

Conclusion

Shinnosuke Tazawa's contributions to the field of pharmaceutical crystallization highlight his role as an innovator. His patents reflect a commitment to improving production methods for essential compounds, which can lead to significant advancements in the pharmaceutical industry.